Fed Regist. 1999 Oct 26;64(206):57700-33.
The Food and Drug Administration (FDA) is authorizing the use, on food labels and in food labeling, of health claims on the association between soy protein and reduced risk of coronary heart disease (CHD). Based on its review of evidence submitted with comments to the proposed rule, as well as evidence described in the proposed rule, the agency has concluded that soy protein included in a diet low in saturated fat and cholesterol may reduce the risk of CHD by lowering blood cholesterol levels.
美国食品药品监督管理局（FDA）现授权在食品标签及食品标识中使用关于大豆蛋白与降低冠心病（CHD）风险之间关联的健康声明。基于对提交给拟议规则的评论中所附证据以及拟议规则中所述证据的审查，该机构得出结论：在饱和脂肪和胆固醇含量低的饮食中包含大豆蛋白，可能通过降低血液胆固醇水平来降低患冠心病的风险。
